Li JH, Yu JP, Yu HG, Xu XM, Yu LL, Liu J, Luo HS Melatonin reduces inflammatory injury through inhibiting NF-kappaB activation in rats with colitis. Mediators Inflamm. 2005 Aug 31;2005(4):185-93.
Lu WZ, Gwee KA, Moochhalla S, Ho KY Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study. Aliment Pharmacol Ther. 2005 Nov 15;22(10):927-34.
Maldonado MD, Calvo JR Melatonin usage in ulcerative colitis: a case report. J Pineal Res. 2008 Oct;45(3):339-40. doi: 10.1111/j.1600-079X.2008.00584.x. Epub 2008 Mar 10.
Song GH, Leng PH, Gwee KA, Moochhala SM, Ho KY Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study. Gut. 2005 Oct;54(10):1402-7. Epub 2005 May 24.
von Gall C, Stehle JH, Weaver DR Mammalian melatonin receptors: molecular biology and signal transduction. Cell Tissue Res. 2002 Jul;309(1):151-62. Epub 2002 May 18. Review.
Melatonin and Ulcerative Colitis: A Pilot Clinical Trial
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
